Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 1.70 and has seen 1.02 million shares traded in the last trading session. The company, currently valued at $314.74M, closed the last trade at $42.78 per share which meant it gained $1.91 on the day or 4.67% during that session. The TNXP stock price is -203.88% off its 52-week high price of $130.00 and 84.2% above the 52-week low of $6.76. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.72 million shares traded. The 3-month trading volume is 891.13K shares.
The consensus among analysts is that Tonix Pharmaceuticals Holding Corp (TNXP) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 5 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Sporting 4.67% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TNXP stock price touched $42.78 or saw a rise of 4.62%. Year-to-date, Tonix Pharmaceuticals Holding Corp shares have moved -31.00%, while the 5-day performance has seen it change 20.71%. Over the past 30 days, the shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have changed 13.44%. Short interest in the company has seen 1.13 million shares shorted with days to cover at 0.85.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
The company’s shares have gained 67.11% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 73.03% over the past 5 years. Earnings growth for 2025 is a modest 93.08% while over the next 5 years, the company’s earnings are expected to increase by 88.07%.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp is expected to release its next earnings report on 2025-May-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Insiders own 0.05% of the company shares, while shares held by institutions stand at 7.03% with a share float percentage of 7.04%. Investors are also buoyed by the number of investors in a company, with Tonix Pharmaceuticals Holding Corp having a total of 32.0 institutions that hold shares in the company. The top two institutional holders are PRUDENTIAL FINANCIAL INC with over 97707.0 shares worth more than $68141.0. As of 2024-06-30, PRUDENTIAL FINANCIAL INC held 0.0239% of shares outstanding.
The other major institutional holder is ALYESKA INVESTMENT GROUP, L.P., with the holding of over 62500.0 shares as of 2024-06-30. The firm’s total holdings are worth over $43588.0 and represent 0.0153% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 1.21% shares in the company for having 88.86 shares of worth $3.8 million while later fund manager owns 30.61 shares of worth $1.31 million as of May 31, 2025 , which makes it owner of about 0.42% of company’s outstanding stock.
